SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Colfax Corp – ‘8-K’ for 3/11/21

On:  Thursday, 3/11/21, at 6:10am ET   ·   For:  3/11/21   ·   Accession #:  1193125-21-76923   ·   File #:  1-34045

Previous ‘8-K’:  ‘8-K’ on 3/5/21 for 3/3/21   ·   Next:  ‘8-K’ on 3/19/21 for 3/16/21   ·   Latest:  ‘8-K’ on 5/14/21 for 5/12/21

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/11/21  Colfax Corp                       8-K:7,9     3/11/21   12:21M                                    Donnelley … Solutions/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    144K 
 8: R1          Document and Entity Information                     HTML     52K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- d149049d8k_htm                      XML     18K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.DEF  XBRL Definitions -- cfx-20210311_def                 XML     41K 
 5: EX-101.LAB  XBRL Labels -- cfx-20210311_lab                      XML     68K 
 6: EX-101.PRE  XBRL Presentations -- cfx-20210311_pre               XML     43K 
 3: EX-101.SCH  XBRL Schema -- cfx-20210311                          XSD     15K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    22K 
12: ZIP         XBRL Zipped Folder -- 0001193125-21-076923-xbrl      Zip     37K 

‘8-K’   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 i Colfax CORP  i false  i 0001420800 0001420800 2021-03-11 2021-03-11 0001420800 us-gaap:CommonStockMember 2021-03-11 2021-03-11 0001420800 us-gaap:CapitalUnitsMember 2021-03-11 2021-03-11








FORM  i 8-K




Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i March 11, 2021



Colfax Corporation

(Exact name of registrant as specified in its charter)




 i Delaware    i 001-34045    i 54-1887631

(State or other jurisdiction

of incorporation)



File Number)


(I.R.S. Employer

Identification No.)

 i 420 National Business Parkway,  i 5th Floor

 i Annapolis Junction,  i MD  i 20701

(Address of principal executive offices) (Zip Code)

 i (301)  i 323-9000

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class





Name of each exchange

on which registered

 i Common Stock, par value $0.001 per share    i CFX    i New York Stock Exchange
 i 5.75% Tangible Equity Units    i CFXA    i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




Item 7.01.

Regulation FD Disclosure.

As previously disclosed, on March 11, 2021, Colfax Corporation (the “Company”) is holding an Investor Day beginning at 9:00 a.m. Eastern time. In connection with this event, the Company will provide additional information with respect to the Company’s previously announced intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent and publicly traded companies, as well as a detailed discussion of each business. A copy of the Investor Day presentation is furnished herewith as Exhibit 99.1.

A live webcast of the event can be accessed beginning at 9:00 a.m. Eastern time through the Company’s website at under the “Investors” section. The Investor Day presentation and replays of the webcast will be available on the Company’s website under the “Investors” section following the event.

The information in Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.


Item 9.01.

Financial Statements and Exhibits.

(d)    Exhibits


99.1    Investor Day presentation, dated March 11, 2021.
104    Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 11, 2021



/s/ Christopher M. Hix

Name:   Christopher M. Hix
Title:   Executive Vice President, Finance

Chief Financial Officer

(Principal Financial Officer)

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:3/11/21None on these Dates
 List all Filings 
Filing Submission 0001193125-21-076923   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Jun. 21, 8:57:59.1am ET